Cataflam and Dyspnea exacerbated - a phase IV clinical study of FDA data

Summary:

Dyspnea exacerbated is reported as a side effect among people who take Cataflam (diclofenac potassium), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Xanax, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Dyspnea exacerbated when taking Cataflam. It is created by eHealthMe based on reports of 1,750 people who have side effects when taking Cataflam from the FDA, and is updated regularly.

What is Cataflam?

Cataflam has active ingredients of diclofenac potassium. It is often used in pain. eHealthMe is studying from 1,851 Cataflam users. Check the latest studies of Cataflam.

What is Dyspnea exacerbated?

Dyspnea exacerbated is found to be associated with 3,270 drugs and 1,653 conditions by eHealthMe. Check the latest studies of Dyspnea exacerbated.

On Jul, 06, 2026

1,750 people reported to have side effects when taking Cataflam.
Among them, 98 people (5.6%) have Dyspnea exacerbated.

Could Cataflam cause Dyspnea exacerbated?

Among these 98 people:

How long have people been on Cataflam when they have Dyspnea exacerbated? *

What is the gender of people who have Dyspnea exacerbated when taking Cataflam? *

female: 65.59 %
male: 34.41 %

What is the age of people who have Dyspnea exacerbated when taking Cataflam? *

What are other drugs people take besides Cataflam? *

What are other side effects people have besides Dyspnea exacerbated? *

Nausea (feeling of having an urge to vomit): 23 people, 23.47%
Fatigue (feeling of tiredness): 21 people, 21.43%
Abdominal Pain Upper: 19 people, 19.39%
Pain In Extremity: 19 people, 19.39%
Weakness: 19 people, 19.39%
Heart Rate Increased: 18 people, 18.37%
Hypersensitivity: 17 people, 17.35%
Dizziness: 16 people, 16.33%
Chest Pain: 16 people, 16.33%
Fever: 15 people, 15.31%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 10 people, 10.20%
Peripheral Swelling: 8 people, 8.16%
Conjunctivitis (pink eye): 8 people, 8.16%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 7 people, 7.14%
Reflux Gastritis (a condition in which the lining of a person's stomach becomes inflamed as a result of exposure to bile): 7 people, 7.14%
Migraine (headache): 7 people, 7.14%
High Blood Pressure: 6 people, 6.12%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 5 people, 5.10%
Ankylosing Spondylitis (type of arthritis affecting the spine): 5 people, 5.10%
Stress And Anxiety: 4 people, 4.08%

* Approximation only. Some reports may have incomplete information.

Do you take Cataflam and have Dyspnea exacerbated?

- Check whether Dyspnea exacerbated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cataflam:

Cataflam (1,851 reports)

Browse all side effects of Cataflam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dyspnea exacerbated:

Dyspnea exacerbated (3,270 drugs)

Browse all the conditions that are associated with Dyspnea exacerbated:

Dyspnea exacerbated (1,653 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on diclofenac potassium (the active ingredients of Cataflam) and Cataflam (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.